ஒருங்கிணைந்த மட்டை நோய் ரேடிஂக் அளவு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒருங்கிணைந்த மட்டை நோய் ரேடிஂக் அளவு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒருங்கிணைந்த மட்டை நோய் ரேடிஂக் அளவு Today - Breaking & Trending Today

Amicus Therapeutics Inc (FOLD) Q4 2020 Earnings Call Transcript


Amicus Therapeutics Inc (FOLD) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Amicus Therapeutics Inc (NASDAQ: FOLD)
Popular Searches
Operator
Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics Fourth Quarter 2020 Fiscal Year Results Conference Call and Webcast. [Operator Instructions] I would now like to turn the conference over to your host, Mr. Andrew Faughnan, Head of Investor Relations. You may begin.
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company s SEC filings. Please ....

United States , University Of Pennsylvania , Mitchell Goldman , Anupam Rama , Bradleyl Campbell , Henri Termeer , Debjit Chattopadhyay , Mohit Bansal Citigroup , Bradley Campbell , Elizabeth Webster Goldman Sachs , Jeffreyp Castelli , Johnf Crowley , Salveen Richter , Daphne Quimi , Andrew Faughnan , Kristen Kluska , Kristen Kluska Cantor Fitzgerald , Jim Wilson , Aaron Welch Guggenheim , Jeff Castelli , Rossella Passero , Fabry Pompe , Anvita Cowen , John Crowley , Tazeen Ahmad , Mohit Bansal ,

Amicus Therapeutics Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Amicus Therapeutics Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene .
Amicus Therapeutics, Inc.February 8, 2021 GMT
Initial Data Suggest Early Signs of Disease Stabilization in Children with
Fatal Neurologic Disease
Plan to Submit IND for Next Clinical Study in 2H2021
PHILADELPHIA, Feb. 08, 2021 (GLOBE NEWSWIRE) Amicus Therapeutics (Nasdaq: FOLD) today announced positive initial results from its first in-human study of its CLN3 Batten disease gene therapy program, AT-GTX-502. The results are featured in a virtual poster presentation at the 17th Annual WORLD
Symposium ™ 2021, being held February 8-12, 2021. The poster is also available in the Events and Presentations section of the Amicus Therapeutics corporate website. ....

United States , Andrew Faughnan , Los Reyes , Diana Moore , Jeff Castelli , Amicus Therapeutics , Abigail Wexner Research Institute , Drug Administration , Head Of Global Corporate Communications , Ohio State University College Of Medicine , Initial Data Suggest Early Signs , Disease Stabilization , Fatal Neurologic , Next Clinical Study , Nationwide Children , Unified Batten Disease Rating Scale , Data Highlights , Batten Disease Rating Scale , Chief Development Officer , Principal Investigator , Clinical Pediatrics , Ohio State University College , Fast Track Designation , Rare Pediatric Designation , United States Food , Orphan Drug ,